Literature DB >> 21447740

Combined treatment of pancreatic cancer with mithramycin a and tolfenamic Acid promotes sp1 degradation and synergistic antitumor activity--letter.

Ting-Chao Chou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21447740     DOI： 10.1158/0008-5472.CAN-11-0379

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  2 in total

1.  A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo.

Authors:  Tao Guo; Zu-Long Liu; Qiang Zhao; Zhi-Min Zhao; Cheng-Hai Liu
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

2.  Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.

Authors:  Yi Zhang; Hai-xuan Chen; Shu-yan Zhou; Shao-xiang Wang; Kai Zheng; Dan-dan Xu; Yu-ting Liu; Xiao-yan Wang; Xiao Wang; Hai-Zhao Yan; Li Zhang; Qiu-ying Liu; Wan-qun Chen; Yi-fei Wang
Journal:  Mol Cancer       Date:  2015-03-07       Impact factor: 27.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.